View Older Stories View More Recent Stories

Mar 7, 2022 07:00AM Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 STIMULON™
Mar 7, 2022 07:00AM Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 STIMULON™
Mar 1, 2022 08:00AM Agenus Corporate Update and Fourth Quarter & Full Year 2021 Financial Report
Mar 1, 2022 08:00AM Agenus Corporate Update and Fourth Quarter & Full Year 2021 Financial Report
Feb 15, 2022 08:30AM Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2021 Financial Report
Feb 15, 2022 08:30AM Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2021 Financial Report
Jan 5, 2022 08:30AM Agenus to Participate at Upcoming Investor Conferences
Jan 5, 2022 08:30AM Agenus to Participate at Upcoming Investor Conferences
Dec 22, 2021 08:32AM Agenus (AGEN) Balstilimab Plus Zalifrelimab Data Published in Journal of Clinical Oncology
Dec 22, 2021 08:30AM Balstilimab Plus Zalifrelimab Data Published in Journal of Clinical Oncology (JCO)
Dec 22, 2021 08:30AM Balstilimab Plus Zalifrelimab Data Published in Journal of Clinical Oncology (JCO)
Nov 17, 2021 08:30AM Agenus to Participate in 4th Annual Evercore ISI HealthCONx Conference
Nov 17, 2021 08:30AM Agenus to Participate in 4th Annual Evercore ISI HealthCONx Conference
Nov 12, 2021 07:00AM Clinical Activity of AGEN1181 Demonstrated Across Nine Treatment-Resistant Cancers at SITC
Nov 12, 2021 07:00AM Clinical Activity of AGEN1181 Demonstrated Across Nine Treatment-Resistant Cancers at SITC
Nov 9, 2021 08:00AM Agenus Corporate Update and Third Quarter 2021 Financial Report
Nov 9, 2021 08:00AM Agenus to Participate in Fireside Chat at the B. Riley Fall 2021 Growth Biotech Best Ideas Series
Nov 9, 2021 08:00AM Agenus Corporate Update and Third Quarter 2021 Financial Report
Nov 9, 2021 08:00AM Agenus to Participate in Fireside Chat at the B. Riley Fall 2021 Growth Biotech Best Ideas Series
Nov 4, 2021 08:30AM Agenus to Participate in Webcast Hosted by William Blair to Discuss AGEN1181 Clinical Data from SITC 2021 Meeting
Nov 4, 2021 08:30AM Agenus to Participate in Webcast Hosted by William Blair to Discuss AGEN1181 Clinical Data from SITC 2021 Meeting
Oct 25, 2021 08:30AM Agenus to Provide Corporate Update and Third Quarter 2021 Financial Report
Oct 25, 2021 08:30AM Agenus to Provide Corporate Update and Third Quarter 2021 Financial Report
Oct 22, 2021 08:03AM Agenus (AGEN) Withdraws Balstilimab BLA
Oct 22, 2021 08:00AM Agenus Provides Update on Balstilimab Development
Oct 22, 2021 08:00AM Agenus Provides Update on Balstilimab Development
Oct 12, 2021 08:31AM Agenus (AGEN) to Receive $20M Milestone Payment from Bristol Myers Squibb with Dosing of First Patient with its TIGIT Bispecific Antibody
Oct 12, 2021 08:30AM Agenus to Receive $20M Milestone Payment from Bristol Myers Squibb with Dosing of First Patient with its TIGIT Bispecific Antibody
Oct 12, 2021 08:30AM Agenus to Receive $20M Milestone Payment from Bristol Myers Squibb with Dosing of First Patient with its TIGIT Bispecific Antibody
Oct 1, 2021 08:00AM Agenus to Present AGEN1181 Clinical Data at SITC
Oct 1, 2021 08:00AM Agenus to Present AGEN1181 Clinical Data at SITC
Sep 17, 2021 05:50AM Agenus's (AGEN) Phase 2 Data Shows Combination of Balstilimab Plus Zalifrelimab Doubles Responses in 2L Cervical Cancer
Sep 16, 2021 06:25PM Combination of Balstilimab Plus Zalifrelimab Doubles Responses in 2L Cervical Cancer in Data to Be Presented at ESMO
Sep 16, 2021 06:25PM Combination of Balstilimab Plus Zalifrelimab Doubles Responses in 2L Cervical Cancer in Data to Be Presented at ESMO
Sep 10, 2021 07:30AM New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Collaboration with Ginkgo Bioworks
Sep 10, 2021 07:30AM New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Collaboration with Ginkgo Bioworks
Sep 9, 2021 08:00AM Agenus to Participate in September Investor Conferences
Sep 9, 2021 08:00AM Agenus to Participate in September Investor Conferences
Aug 26, 2021 09:00AM Balstilimab Monotherapy Data Published in Gynecologic Oncology
Aug 26, 2021 09:00AM Balstilimab Monotherapy Data Published in Gynecologic Oncology
Aug 9, 2021 07:45AM Agenus Corporate Update and Second Quarter 2021 Financial Report
Aug 9, 2021 07:45AM Agenus Corporate Update and Second Quarter 2021 Financial Report
Aug 2, 2021 04:05PM Agenus to Participate in the BTIG Virtual Biotechnology Conference 2021
Aug 2, 2021 04:05PM Agenus to Participate in the BTIG Virtual Biotechnology Conference 2021
Jul 28, 2021 06:59AM Bristol Myers Squibb Reports Second Quarter Financial Results for 2021
Jul 26, 2021 04:05PM Agenus to Provide Corporate Update and Second Quarter 2021 Financial Report
Jul 26, 2021 04:05PM Agenus to Provide Corporate Update and Second Quarter 2021 Financial Report
Jul 7, 2021 04:05PM Agenus to Participate in Resistance-Focused Oncology Panel at the William Blair Biotech Focus Conference 2021
Jul 7, 2021 04:05PM Agenus to Participate in Resistance-Focused Oncology Panel at the William Blair Biotech Focus Conference 2021
Jul 6, 2021 08:34AM Agenus (AGEN) Closes $200M Upfront BMS Collaboration and Announces FDA Acceptance of IND for Partnered Anti-TIGIT Bispecific Antibody, AGEN1777
View More Recent Stories View Older Stories